Leif G. Suhrland

501 total citations
23 papers, 381 citations indexed

About

Leif G. Suhrland is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leif G. Suhrland has authored 23 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leif G. Suhrland's work include Selenium in Biological Systems (3 papers), Cancer Research and Treatments (3 papers) and Platelet Disorders and Treatments (3 papers). Leif G. Suhrland is often cited by papers focused on Selenium in Biological Systems (3 papers), Cancer Research and Treatments (3 papers) and Platelet Disorders and Treatments (3 papers). Leif G. Suhrland collaborates with scholars based in United States. Leif G. Suhrland's co-authors include Austin S. Weisberger, Nikolay V. Dimitrov, Ernie Balcueva, Thomas M. Daniel, James R. Egner, Joseph Seifter, Robert C. Griggs, Frederick J. Bonte, Edward R. Arquilla and Aaron P. Scholnik and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

Leif G. Suhrland

21 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leif G. Suhrland United States 10 84 80 74 51 50 23 381
Frank H. Bethell United States 14 54 0.6× 34 0.4× 122 1.6× 29 0.6× 15 0.3× 48 567
Benoy B. Paul United States 6 29 0.3× 37 0.5× 66 0.9× 32 0.6× 23 0.5× 8 340
B. A. Skålhegg Norway 12 54 0.6× 57 0.7× 85 1.1× 133 2.6× 22 0.4× 18 484
Fillastre Jp France 9 44 0.5× 14 0.2× 58 0.8× 37 0.7× 72 1.4× 81 316
I Kupke Germany 9 40 0.5× 49 0.6× 96 1.3× 73 1.4× 15 0.3× 25 399
J Vaysse France 14 46 0.5× 18 0.2× 130 1.8× 22 0.4× 35 0.7× 34 478
P. Bonvicini Italy 8 77 0.9× 30 0.4× 120 1.6× 38 0.7× 12 0.2× 20 442
Fred Buddingh United States 10 16 0.2× 82 1.0× 121 1.6× 82 1.6× 23 0.5× 17 429
Bruce Wr Canada 9 30 0.4× 48 0.6× 122 1.6× 158 3.1× 12 0.2× 25 451
Roger W. O’Gara United States 12 38 0.5× 12 0.1× 134 1.8× 46 0.9× 17 0.3× 34 471

Countries citing papers authored by Leif G. Suhrland

Since Specialization
Citations

This map shows the geographic impact of Leif G. Suhrland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif G. Suhrland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif G. Suhrland more than expected).

Fields of papers citing papers by Leif G. Suhrland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leif G. Suhrland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif G. Suhrland. The network helps show where Leif G. Suhrland may publish in the future.

Co-authorship network of co-authors of Leif G. Suhrland

This figure shows the co-authorship network connecting the top 25 collaborators of Leif G. Suhrland. A scholar is included among the top collaborators of Leif G. Suhrland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leif G. Suhrland. Leif G. Suhrland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suhrland, Leif G., et al.. (2007). A comparative study by electron microscopy of the morphology of Mycobacterium leprae and cultivable species of mycobacteria.. PubMed. 16(3). 361–6.
2.
Scholnik, Aaron P., et al.. (1988). High-Dose Folinic Acid and 5-Fluorouracil in the Treatment of Advanced Colon Cancer. American Journal of Clinical Oncology. 11(5). 558–563. 4 indexed citations
3.
Aabo, Kristian, Edward H. Romond, Nikolay V. Dimitrov, Thomas N. Denny, & Leif G. Suhrland. (1983). Pancreatic islet cell carcinoma associated with multiple hormone secretion and pancytopenia. Evidence of a serum factor suppressing hematopoiesis. Cancer. 51(9). 1691–1696. 4 indexed citations
4.
Dimitrov, Nikolay V., James R. Egner, Ernie Balcueva, & Leif G. Suhrland. (1982). High-dose methotrexate with citrovorum factor and vincristine in the treatment of malignant mesothelioma. Cancer. 50(7). 1245–1247. 33 indexed citations
5.
Weir, David R., Nikolay V. Dimitrov, Harold B. Houser, Leif G. Suhrland, & Than Myint. (1969). Serum proteins and blood vitamins in anemia of the chronically ill. Journal of Chronic Diseases. 22(6-7). 407–419. 1 indexed citations
6.
Suhrland, Leif G. & Austin S. Weisberger. (1969). Delayed Clearance of Chloramphenicol from Serum in Patients with Hematologic Toxicity. Blood. 34(4). 466–471. 14 indexed citations
7.
Daniel, Thomas M., Leif G. Suhrland, & Austin S. Weisberger. (1965). Suppression of the Anamnestic Response to Tetanus Toxoid in Man by Chloramphenicol. New England Journal of Medicine. 273(7). 367–369. 23 indexed citations
8.
Suhrland, Leif G.. (1965). Intracavitary 5-Fluorouracil in Malignant Effusions. Archives of Internal Medicine. 116(3). 431–431. 55 indexed citations
9.
Suhrland, Leif G., et al.. (1963). Correlation of Erythropoietic Toxicity with the Serum Concentration of Chloramphenicol Metabolites in Patients with Renal or Hepatic Insufficiency.. Annals of Internal Medicine. 58(4). 731–731. 1 indexed citations
10.
Suhrland, Leif G.. (1963). Chloramphenicol Toxicity in Liver and Renal Disease. Archives of Internal Medicine. 112(5). 747–747. 60 indexed citations
11.
Suhrland, Leif G. & Austin S. Weisberger. (1962). HEMATOLOGIC TOXICITY OF A CHLORAMPHENICOL ANALOGUE. The American Journal of the Medical Sciences. 244(1). 16–22. 9 indexed citations
12.
Weisberger, Austin S. & Leif G. Suhrland. (1958). MASSIVE CORTICOSTEROID THERAPY IN THE MANAGEMENT OF RESISTANT THROMBOCYTOPENIC PURPURA. The American Journal of the Medical Sciences. 236(4). 425–433. 1 indexed citations
13.
Suhrland, Leif G., Edward R. Arquilla, & Austin S. Weisberger. (1958). The effect of prednisolone on circulating antibody formation in animals immunized with human platelet antigen.. PubMed. 51(5). 724–30. 5 indexed citations
14.
Weisberger, Austin S. & Leif G. Suhrland. (1958). MASSIVE CORTICOSTEROID THERAPY IN THE MANAGEMENT OF RESISTANT THROMBOCYTOPENIC PURPURA. The American Journal of the Medical Sciences. 236(4). 425–433. 1 indexed citations
15.
Weisberger, Austin S. & Leif G. Suhrland. (1956). Studies on Analogues of L-Cysteine and L-Cystine. Blood. 11(1). 11–18. 38 indexed citations
16.
Weisberger, Austin S. & Leif G. Suhrland. (1956). Studies on Analogues of L-Cysteine and L-Cystine. Blood. 11(1). 19–30. 63 indexed citations
17.
Weisberger, Austin S., Leif G. Suhrland, & Joseph Seifter. (1956). Studies on Analogues of L-Cysteine and L-Cystine. Blood. 11(1). 1–10. 22 indexed citations
18.
Weisberger, Austin S., Frederick J. Bonte, & Leif G. Suhrland. (1956). Management of malignant serous effusions.. PubMed. 11(1). 23–30. 7 indexed citations
19.
Suhrland, Leif G.. (1954). RECTAL ADMINISTRATION OF URETHANE IN LEUKEMIA. Journal of the American Medical Association. 154(17). 1415–1415. 7 indexed citations
20.
Weisberger, Austin S., Leif G. Suhrland, & Robert C. Griggs. (1954). Incorporation of Radioactive L-Cystine and L-Methionine by Leukemic Leukocytes in Vitro. Blood. 9(11). 1095–1104. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank H. Bethell Breakdown of academic impact, for papers by Benoy B. Paul Breakdown of academic impact, for papers by B. A. Skålhegg Breakdown of academic impact, for papers by Fillastre Jp Breakdown of academic impact, for papers by I Kupke Breakdown of academic impact, for papers by J Vaysse Breakdown of academic impact, for papers by P. Bonvicini Breakdown of academic impact, for papers by Fred Buddingh Breakdown of academic impact, for papers by Bruce Wr Breakdown of academic impact, for papers by Roger W. O’Gara
Rankless by CCL
2026